23,036,271
Vote Records
25,695
Companies
11,771
Funds
3,902
Managers

Home › Companies › ARCTURUS THERAPEUTICS HOLDINGS INC. › 2023-2024

ARCTURUS THERAPEUTICS HOLDINGS INC. 2023-2024 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and ARCTURUS THERAPEUTICS HOLDINGS INC.’s Form 8-K, filed June 14, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 11Ballot items
  • 209Asset managers, any item
  • 2,733Fund votes
  • June 14, 2024Meeting date

Results at a glance

Meeting of June 14, 2024: 11 items on ARCTURUS THERAPEUTICS HOLDINGS INC.’s Form 8-K, filed June 14, 2024: 8 elected · 3 approved.

Dissent

Notable dissent: 1 other board item (35.3% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore ARCTURUS THERAPEUTICS HOLDINGS INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by ARCTURUS THERAPEUTICS HOLDINGS INC.

These tallies are ARCTURUS THERAPEUTICS HOLDINGS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 14, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

ARCTURUS THERAPEUTICS HOLDINGS INC. — official shareholder meeting results, meeting held June 14, 2024
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Dr. Peter Farrell 20,844,568---- 159,5542,305,768 99.2%Elected—
Elect Director: Joseph E. Payne 20,922,344---- 81,7782,305,768 99.6%Elected—
Elect Director: Andy Sassine 20,734,162---- 269,9602,305,768 99%Elected—
Elect Director: James Barlow 20,454,267---- 549,8552,305,768 97%Elected—
Elect Director: Dr. Edward W. Holmes 19,895,980---- 1,108,1422,305,768 95%Elected—
Elect Director: Dr. Magda Marquet 20,414,805---- 589,3172,305,768 97%Elected—
Elect Director: Dr. Jing L. Marantz 20,390,182---- 613,9402,305,768 97%Elected—
Elect Director: Dr. John H. Markels 20,740,090---- 264,0322,305,768 99%Elected—
Approval of the Amendment to the Company's Plan, as provided in Proposal Number 2 of the Proxy Statement 13,464,4347,356,256183,432 --2,305,768 65%Approved—
Approval, on a non-binding advisory basis, the resolution approving named executive officer compensation , referred to as "say-on-pay," as provided in Proposal Number 3 of the Proxy Statement 19,875,9301,069,59258,600 --2,305,768 95%Approved—
Approval of the ratification of the appointment of Deloitte as the Company's independent registered public accounting firm for the year ending December 31, 2024, as provided in Proposal Number 4 of the Proxy Statement 23,267,44930,12012,321 ---- 99.9%Approved—

Source: ARCTURUS THERAPEUTICS HOLDINGS INC., Form 8-K, filed with the SEC on June 14, 2024 — read the filing on EDGAR.

How asset managers voted at the ARCTURUS THERAPEUTICS HOLDINGS INC. 2023-2024 meeting

209 asset managers disclosed a vote on at least one ARCTURUS THERAPEUTICS HOLDINGS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: Andy Sassine

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 20,734,162WITHHELD: 269,960

Prior year: 99.3% for (June 14, 2023 meeting) ▼ 0.6 pts

Details: description as filed, official tally, votes by 74 asset managers

Description as filed by funds: Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Andy Sassine

ARCTURUS THERAPEUTICS HOLDINGS INC.’s own tally for this item (“Elect Director: Andy Sassine”): 20,734,162 for, 269,960 withheld, per its Form 8-K filed June 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Approval of the election of the following individuals as directors of the Company, as provided in Proposal Number 1 of the Proxy Statement: (1) Dr. Peter Farrell | 20,844,568 | 159,554 | 2,305,768 (2) Joseph E. Payne | 20,922,344 | 81,778 | 2,305,768 (3) Andy Sassine | 20,734,162 | 269,960 | 2,305,…”
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 74 asset managers below reported 11,714,589 for, 67,332 withheld, 257 abstained.

FOR
FOR: 11,714,589ABSTAIN: 257WITHHOLD: 67,332
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at ARCTURUS THERAPEUTICS HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,695,3720 00For
ARK ETF Trust1,743,6660 00For
Vanguard1,310,5850 00For
Fidelity843,5270 00For
Dimensional531,5980 00For
BlackRock489,1660 00For
State Street239,9520 022For
Charles Schwab191,0330 00For
Hartford177,3130 00For
American Century175,1410 00For
Royce129,8360 00For
Jackson National127,4370 00For
Direxion Shares ETF Trust115,9410 00For
TIAA92,5200 00For
Equitable65,2200 00For
Harbor Funds II60,8800 00For
Goldman Sachs59,4160 00For
QUANTITATIVE MASTER SERIES LLC43,4630 00For
Northwestern Mutual43,1370 00For
MFS42,5470 00For
Neuberger Berman00 041,348Withhold
John Hancock36,3610 00For
Lincoln Financial35,3590 00For
Nushares ETF Trust30,1590 00For
JPMorgan29,8190 00For

Showing the 25 largest of 74 asset managers. All 74 are in the interactive database (link above).

Elect Director: Dr. Edward W. Holmes

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 2 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 19,895,980WITHHELD: 1,108,142

Prior year: 95.6% for (June 14, 2023 meeting) ▼ 0.8 pts

Details: description as filed, official tally, votes by 74 asset managers

Description as filed by funds: Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Edward W. Holmes

ARCTURUS THERAPEUTICS HOLDINGS INC.’s own tally for this item (“Elect Director: Dr. Edward W. Holmes”): 19,895,980 for, 1,108,142 withheld, per its Form 8-K filed June 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Approval of the election of the following individuals as directors of the Company, as provided in Proposal Number 1 of the Proxy Statement: (1) Dr. Peter Farrell | 20,844,568 | 159,554 | 2,305,768 (2) Joseph E. Payne | 20,922,344 | 81,778 | 2,305,768 (3) Andy Sassine | 20,734,162 | 269,960 | 2,305,…”
Support: 95% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 74 asset managers below reported 11,455,683 for, 326,238 withheld, 257 abstained.

FOR
FOR: 11,455,683ABSTAIN: 257WITHHOLD: 326,238
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at ARCTURUS THERAPEUTICS HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,695,3720 00For
ARK ETF Trust1,743,6660 00For
Vanguard1,310,5850 00For
Fidelity843,5270 00For
Dimensional531,5980 00For
BlackRock489,1660 00For
State Street4460 0239,528Withhold
Charles Schwab191,0330 00For
Hartford177,3130 00For
American Century175,1410 00For
Royce129,8360 00For
Jackson National127,4370 00For
Direxion Shares ETF Trust115,9410 00For
TIAA92,5200 00For
Equitable65,2200 00For
Harbor Funds II60,8800 00For
Goldman Sachs59,4160 00For
QUANTITATIVE MASTER SERIES LLC43,4630 00For
Northwestern Mutual43,1370 00For
MFS42,5470 00For
Neuberger Berman41,3480 00For
John Hancock36,3610 00For
Lincoln Financial15,5590 019,800Mixed
Nushares ETF Trust30,1590 00For
JPMorgan29,8190 00For

Showing the 25 largest of 74 asset managers. All 74 are in the interactive database (link above).

Elect Director: Dr. Jing L. Marantz

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 2 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 20,390,182WITHHELD: 613,940

Prior year: 95.8% for (June 14, 2023 meeting) ▲ 1.3 pts

Details: description as filed, official tally, votes by 74 asset managers

Description as filed by funds: Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Jing L. Marantz

ARCTURUS THERAPEUTICS HOLDINGS INC.’s own tally for this item (“Elect Director: Dr. Jing L. Marantz”): 20,390,182 for, 613,940 withheld, per its Form 8-K filed June 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Approval of the election of the following individuals as directors of the Company, as provided in Proposal Number 1 of the Proxy Statement: (1) Dr. Peter Farrell | 20,844,568 | 159,554 | 2,305,768 (2) Joseph E. Payne | 20,922,344 | 81,778 | 2,305,768 (3) Andy Sassine | 20,734,162 | 269,960 | 2,305,…”
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 74 asset managers below reported 11,386,748 for, 395,430 withheld.

FOR
FOR: 11,386,748WITHHOLD: 395,430
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at ARCTURUS THERAPEUTICS HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,695,3720 00For
ARK ETF Trust1,743,6660 00For
Vanguard1,310,5850 00For
Fidelity476,4760 0367,051Mixed
Dimensional531,5980 00For
BlackRock489,1660 00For
State Street239,9260 048For
Charles Schwab191,0330 00For
Hartford177,3130 00For
American Century175,1410 00For
Royce129,8360 00For
Jackson National127,4370 00For
Direxion Shares ETF Trust115,9410 00For
TIAA92,5200 00For
Equitable65,2200 00For
Harbor Funds II60,8800 00For
Goldman Sachs59,4160 00For
QUANTITATIVE MASTER SERIES LLC43,4630 00For
Northwestern Mutual43,1370 00For
MFS42,5470 00For
Neuberger Berman41,3480 00For
John Hancock36,3610 00For
Lincoln Financial35,3590 00For
Nushares ETF Trust30,1590 00For
JPMorgan29,8190 00For

Showing the 25 largest of 74 asset managers. All 74 are in the interactive database (link above).

Elect Director: Dr. John H. Markels

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 20,740,090WITHHELD: 264,032

Prior year: 99.8% for (June 14, 2023 meeting) ▼ 1.0 pts

Details: description as filed, official tally, votes by 74 asset managers

Description as filed by funds: Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. John Markels

ARCTURUS THERAPEUTICS HOLDINGS INC.’s own tally for this item (“Elect Director: Dr. John H. Markels”): 20,740,090 for, 264,032 withheld, per its Form 8-K filed June 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Approval of the election of the following individuals as directors of the Company, as provided in Proposal Number 1 of the Proxy Statement: (1) Dr. Peter Farrell | 20,844,568 | 159,554 | 2,305,768 (2) Joseph E. Payne | 20,922,344 | 81,778 | 2,305,768 (3) Andy Sassine | 20,734,162 | 269,960 | 2,305,…”
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 74 asset managers below reported 11,753,799 for, 28,379 withheld.

FOR
FOR: 11,753,799WITHHOLD: 28,379
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at ARCTURUS THERAPEUTICS HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,695,3720 00For
ARK ETF Trust1,743,6660 00For
Vanguard1,310,5850 00For
Fidelity843,5270 00For
Dimensional531,5980 00For
BlackRock489,1660 00For
State Street239,9260 048For
Charles Schwab191,0330 00For
Hartford177,3130 00For
American Century175,1410 00For
Royce129,8360 00For
Jackson National127,4370 00For
Direxion Shares ETF Trust115,9410 00For
TIAA92,5200 00For
Equitable65,2200 00For
Harbor Funds II60,8800 00For
Goldman Sachs59,4160 00For
QUANTITATIVE MASTER SERIES LLC43,4630 00For
Northwestern Mutual43,1370 00For
MFS42,5470 00For
Neuberger Berman41,3480 00For
John Hancock36,3610 00For
Lincoln Financial35,3590 00For
Nushares ETF Trust30,1590 00For
JPMorgan29,8190 00For

Showing the 25 largest of 74 asset managers. All 74 are in the interactive database (link above).

Elect Director: Dr. Magda Marquet

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 2 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 20,414,805WITHHELD: 589,317

Prior year: 66.8% for (June 14, 2023 meeting) ▲ 30.4 pts

Details: description as filed, official tally, votes by 74 asset managers

Description as filed by funds: Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Magda Marquet

ARCTURUS THERAPEUTICS HOLDINGS INC.’s own tally for this item (“Elect Director: Dr. Magda Marquet”): 20,414,805 for, 589,317 withheld, per its Form 8-K filed June 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Approval of the election of the following individuals as directors of the Company, as provided in Proposal Number 1 of the Proxy Statement: (1) Dr. Peter Farrell | 20,844,568 | 159,554 | 2,305,768 (2) Joseph E. Payne | 20,922,344 | 81,778 | 2,305,768 (3) Andy Sassine | 20,734,162 | 269,960 | 2,305,…”
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 74 asset managers below reported 11,415,105 for, 367,073 withheld.

FOR
FOR: 11,415,105WITHHOLD: 367,073
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at ARCTURUS THERAPEUTICS HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,695,3720 00For
ARK ETF Trust1,743,6660 00For
Vanguard1,310,5850 00For
Fidelity476,4760 0367,051Mixed
Dimensional531,5980 00For
BlackRock489,1660 00For
State Street239,9520 022For
Charles Schwab191,0330 00For
Hartford177,3130 00For
American Century175,1410 00For
Royce129,8360 00For
Jackson National127,4370 00For
Direxion Shares ETF Trust115,9410 00For
TIAA92,5200 00For
Equitable65,2200 00For
Harbor Funds II60,8800 00For
Goldman Sachs59,4160 00For
QUANTITATIVE MASTER SERIES LLC43,4630 00For
Northwestern Mutual43,1370 00For
MFS42,5470 00For
Neuberger Berman41,3480 00For
John Hancock36,3610 00For
Lincoln Financial35,3590 00For
Nushares ETF Trust30,1590 00For
JPMorgan29,8190 00For

Showing the 25 largest of 74 asset managers. All 74 are in the interactive database (link above).

Elect Director: Dr. Peter Farrell

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 2 wordings of this item as funds reported it.

99.2% Majority: yes · of votes cast

FOR 99.2%
FOR: 20,844,568WITHHELD: 159,554

Prior year: 99.4% for (June 14, 2023 meeting) ▼ 0.1 pts

Details: description as filed, official tally, votes by 74 asset managers

Description as filed by funds: Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Peter Farrell

ARCTURUS THERAPEUTICS HOLDINGS INC.’s own tally for this item (“Elect Director: Dr. Peter Farrell”): 20,844,568 for, 159,554 withheld, per its Form 8-K filed June 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Approval of the election of the following individuals as directors of the Company, as provided in Proposal Number 1 of the Proxy Statement: (1) Dr. Peter Farrell | 20,844,568 | 159,554 | 2,305,768 (2) Joseph E. Payne | 20,922,344 | 81,778 | 2,305,768 (3) Andy Sassine | 20,734,162 | 269,960 | 2,305,…”
Support: 99.2% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 74 asset managers below reported 11,782,156 for, 22 withheld.

FOR
FOR: 11,782,156WITHHOLD: 22
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at ARCTURUS THERAPEUTICS HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,695,3720 00For
ARK ETF Trust1,743,6660 00For
Vanguard1,310,5850 00For
Fidelity843,5270 00For
Dimensional531,5980 00For
BlackRock489,1660 00For
State Street239,9520 022For
Charles Schwab191,0330 00For
Hartford177,3130 00For
American Century175,1410 00For
Royce129,8360 00For
Jackson National127,4370 00For
Direxion Shares ETF Trust115,9410 00For
TIAA92,5200 00For
Equitable65,2200 00For
Harbor Funds II60,8800 00For
Goldman Sachs59,4160 00For
QUANTITATIVE MASTER SERIES LLC43,4630 00For
Northwestern Mutual43,1370 00For
MFS42,5470 00For
Neuberger Berman41,3480 00For
John Hancock36,3610 00For
Lincoln Financial35,3590 00For
Nushares ETF Trust30,1590 00For
JPMorgan29,8190 00For

Showing the 25 largest of 74 asset managers. All 74 are in the interactive database (link above).

Elect Director: James Barlow

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 2 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 20,454,267WITHHELD: 549,855

Prior year: 95.8% for (June 14, 2023 meeting) ▲ 1.6 pts

Details: description as filed, official tally, votes by 74 asset managers

Description as filed by funds: Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: James Barlow

ARCTURUS THERAPEUTICS HOLDINGS INC.’s own tally for this item (“Elect Director: James Barlow”): 20,454,267 for, 549,855 withheld, per its Form 8-K filed June 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Approval of the election of the following individuals as directors of the Company, as provided in Proposal Number 1 of the Proxy Statement: (1) Dr. Peter Farrell | 20,844,568 | 159,554 | 2,305,768 (2) Joseph E. Payne | 20,922,344 | 81,778 | 2,305,768 (3) Andy Sassine | 20,734,162 | 269,960 | 2,305,…”
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 74 asset managers below reported 11,389,695 for, 392,483 withheld.

FOR
FOR: 11,389,695WITHHOLD: 392,483
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at ARCTURUS THERAPEUTICS HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,695,3720 00For
ARK ETF Trust1,743,6660 00For
Vanguard1,310,5850 00For
Fidelity476,4760 0367,051Mixed
Dimensional531,5980 00For
BlackRock489,1660 00For
State Street239,9520 022For
Charles Schwab191,0330 00For
Hartford177,3130 00For
American Century175,1410 00For
Royce129,8360 00For
Jackson National127,4370 00For
Direxion Shares ETF Trust115,9410 00For
TIAA92,5200 00For
Equitable39,8100 025,410Mixed
Harbor Funds II60,8800 00For
Goldman Sachs59,4160 00For
QUANTITATIVE MASTER SERIES LLC43,4630 00For
Northwestern Mutual43,1370 00For
MFS42,5470 00For
Neuberger Berman41,3480 00For
John Hancock36,3610 00For
Lincoln Financial35,3590 00For
Nushares ETF Trust30,1590 00For
JPMorgan29,8190 00For

Showing the 25 largest of 74 asset managers. All 74 are in the interactive database (link above).

Elect Director: Joseph E. Payne

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 2 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%
FOR: 20,922,344WITHHELD: 81,778

Prior year: 99.6% for (June 14, 2023 meeting) unchanged

Details: description as filed, official tally, votes by 74 asset managers

Description as filed by funds: Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Joseph E. Payne

ARCTURUS THERAPEUTICS HOLDINGS INC.’s own tally for this item (“Elect Director: Joseph E. Payne”): 20,922,344 for, 81,778 withheld, per its Form 8-K filed June 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Approval of the election of the following individuals as directors of the Company, as provided in Proposal Number 1 of the Proxy Statement: (1) Dr. Peter Farrell | 20,844,568 | 159,554 | 2,305,768 (2) Joseph E. Payne | 20,922,344 | 81,778 | 2,305,768 (3) Andy Sassine | 20,734,162 | 269,960 | 2,305,…”
Support: 99.6% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 74 asset managers below reported 11,782,156 for, 22 withheld.

FOR
FOR: 11,782,156WITHHOLD: 22
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at ARCTURUS THERAPEUTICS HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,695,3720 00For
ARK ETF Trust1,743,6660 00For
Vanguard1,310,5850 00For
Fidelity843,5270 00For
Dimensional531,5980 00For
BlackRock489,1660 00For
State Street239,9520 022For
Charles Schwab191,0330 00For
Hartford177,3130 00For
American Century175,1410 00For
Royce129,8360 00For
Jackson National127,4370 00For
Direxion Shares ETF Trust115,9410 00For
TIAA92,5200 00For
Equitable65,2200 00For
Harbor Funds II60,8800 00For
Goldman Sachs59,4160 00For
QUANTITATIVE MASTER SERIES LLC43,4630 00For
Northwestern Mutual43,1370 00For
MFS42,5470 00For
Neuberger Berman41,3480 00For
John Hancock36,3610 00For
Lincoln Financial35,3590 00For
Nushares ETF Trust30,1590 00For
JPMorgan29,8190 00For

Showing the 25 largest of 74 asset managers. All 74 are in the interactive database (link above).

Approval of the Amendment to the Company's Plan, as provided in Proposal Number 2 of the Proxy Statement

Official resultSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 3 wordings of this item as funds reported it.

65% Approved · of votes cast

FOR 65%AGAINST
FOR: 13,464,434AGAINST: 7,356,256
Details: description as filed, official tally, votes by 75 asset managers

Description as filed by funds: To approve an amendment to the Amended and Restated 2019 Omnibus Equity Incentive Plan (as amended, the "Plan") to, among other things, increase the maximum number of shares of common stock available to Plan participants thereunder by 2,000,000 shares to an aggregate of 10,750,000 shares, as provided in Proposal Number 2 of the Proxy Statement.

ARCTURUS THERAPEUTICS HOLDINGS INC.’s own tally for this item (“Approval of the Amendment to the Company's Plan, as provided in Proposal Number 2 of the Proxy Statement”): 13,464,434 for, 7,356,256 against — passed, per its Form 8-K filed June 14, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The proposal was approved.”
Support: 65% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 75 asset managers below reported 9,012,587 for, 2,637,873 against, 131,718 abstained.

FORAGAINST
FOR: 9,012,587AGAINST: 2,637,873ABSTAIN: 131,718
Largest asset managers voting on “To approve an amendment to the Amended and Restated 2019 Omnibus Equity Incentive Plan (as amended, the "Plan"” at ARCTURUS THERAPEUTICS HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,695,3720 00For
ARK ETF Trust1,743,6660 00For
Vanguard1,310,5850 00For
Fidelity13,699829,828 00Against
Dimensional0531,598 00Against
BlackRock489,1660 00For
State Street210239,764 00Against
Charles Schwab191,0330 00For
Hartford177,3130 00For
American Century0175,141 00Against
Royce00 129,8360Abstain
Jackson National0127,437 00Against
Direxion Shares ETF Trust0115,941 00Against
TIAA092,520 00Against
Equitable39,81025,410 00Mixed
Harbor Funds II60,8800 00For
Goldman Sachs059,416 00Against
QUANTITATIVE MASTER SERIES LLC43,4630 00For
Northwestern Mutual43,1370 00For
MFS042,547 00Against
Neuberger Berman41,3480 00For
John Hancock27,2809,081 00Mixed
Lincoln Financial035,359 00Against
Nushares ETF Trust030,159 00Against
JPMorgan029,819 00Against

Showing the 25 largest of 75 asset managers. All 75 are in the interactive database (link above).

Approval, on a non-binding advisory basis, the resolution approving named executive officer compensation , referred to…

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 9 wordings of this item as funds reported it.

95% Approved · of votes cast

FOR 95%
FOR: 19,875,930AGAINST: 1,069,592

Prior year: 72.4% for (June 14, 2023 meeting) ▲ 22.5 pts

Details: description as filed, official tally, votes by 207 asset managers

Description as filed by funds: Approval, by non-binding advisory vote, of the resolution approving the Company's Named Executive Officer compensation, as provided in Proposal Number 3 of the Proxy Statement.

ARCTURUS THERAPEUTICS HOLDINGS INC.’s own tally for this item (“Approval, on a non-binding advisory basis, the resolution approving named executive officer compensation , referred to as "say-on-pay," as provided in Proposal Number 3 of the Proxy Statement”): 19,875,930 for, 1,069,592 against — passed, per its Form 8-K filed June 14, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The proposal was approved.”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 76 asset managers voting on “Approval, by non-binding advisory vote, of the resolution approving the Company's Named Executive Officer comp” at ARCTURUS THERAPEUTICS HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,695,3720 00For
ARK ETF Trust1,743,6660 00For
Vanguard1,310,5850 00For
Fidelity476,476367,051 00Mixed
Dimensional531,5980 00For
BlackRock489,1660 00For
State Street239,92648 00For
Charles Schwab191,0330 00For
Hartford177,3130 00For
American Century0175,141 00Against
Royce129,8360 00For
Jackson National127,4370 00For
Direxion Shares ETF Trust115,9410 00For
TIAA92,5200 00For
Equitable65,2200 00For
Harbor Funds II60,8800 00For
Goldman Sachs59,4160 00For
QUANTITATIVE MASTER SERIES LLC43,4630 00For
Northwestern Mutual43,1370 00For
MFS42,5470 00For
Neuberger Berman41,3480 00For
John Hancock36,3610 00For
Lincoln Financial35,3590 00For
Nushares ETF Trust30,1590 00For
JPMorgan29,8190 00For

Fund voting reports, all 76 managers: 11,188,246 for, 617,585 against. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 154 asset managers voting on “Approval, by non-binding advisory vote, of the resolution approving the Company's Named Executive Officer comp” at ARCTURUS THERAPEUTICS HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,695,3720 00For
Nikko Asset Management Americas, Inc.1,117,1190 00For
ADAGE CAPITAL PARTNERS GP, L.L.C.930,0000 00For
BlackRock655,3179,999 00For
State Street590,61593 00For
Putnam522,6400 00For
Woodline Partners LP485,3960 00For
Wellington447,3430 00For
JUPITER ASSET MANAGEMENT LTD419,1250 00For
Fidelity0368,402 00Against
GEODE CAPITAL MANAGEMENT, LLC313,1480 00For
JPMorgan307,4440 00For
Granahan Investment Management, LLC297,0420 00For
Portolan Capital Management, LLC268,2640 00For
Charles Schwab191,0330 00For
American Century0178,411 00Against
Nikko Asset Management Co., Ltd.159,9800 00For
UBS0126,677 00Against
Nuveen123,8120 00For
Northern Trust115,7521,086 00For
Rafferty Asset Management, LLC115,9410 00For
Dimensional108,0020 00For
Neuberger Berman84,6990 00For
Connor, Clark & Lunn Investment Management Ltd.76,5210 00For
NORDEA INVESTMENT MANAGEMENT AB057,325 00Against

Institutional-manager reports, all 154 managers: 12,738,922 for, 903,269 against. Showing the 25 largest; every one is in the interactive database (link above).

Approval of the ratification of the appointment of Deloitte as the Company's independent registered public accounting…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 5 wordings of this item as funds reported it.

99.9% Approved · of votes cast

FOR 99.9%
FOR: 23,267,449AGAINST: 30,120

Prior year: 99.9% for (June 14, 2023 meeting) unchanged

Details: description as filed, official tally, votes by 77 asset managers

Description as filed by funds: Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.

ARCTURUS THERAPEUTICS HOLDINGS INC.’s own tally for this item (“Approval of the ratification of the appointment of Deloitte as the Company's independent registered public accounting firm for the year ending December 31, 2024, as provided in Proposal Number 4 of the Proxy Statement”): 23,267,449 for, 30,120 against — passed, per its Form 8-K filed June 14, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Approval of the ratification of the appointment of Deloitte as the Company's independent registered public accounting firm for the year ending December 31, 2024, as provided in Proposal Number 4 of the Proxy Statement”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 77 asset managers below reported 11,805,607 for.

FOR
FOR: 11,805,607
Largest asset managers voting on “Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accoun” at ARCTURUS THERAPEUTICS HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,695,3720 00For
ARK ETF Trust1,743,6660 00For
Vanguard1,310,5850 00For
Fidelity843,5270 00For
Dimensional531,5980 00For
BlackRock489,1660 00For
State Street239,9740 00For
Charles Schwab191,0330 00For
Hartford177,3130 00For
American Century175,1410 00For
Royce129,8360 00For
Jackson National127,4370 00For
Direxion Shares ETF Trust115,9410 00For
TIAA92,5200 00For
Equitable65,2200 00For
Harbor Funds II60,8800 00For
Goldman Sachs59,4160 00For
QUANTITATIVE MASTER SERIES LLC43,4630 00For
Northwestern Mutual43,1370 00For
MFS42,5470 00For
Neuberger Berman41,3480 00For
John Hancock36,3610 00For
Lincoln Financial35,3590 00For
Nushares ETF Trust30,1590 00For
JPMorgan29,8190 00For

Showing the 25 largest of 77 asset managers. All 77 are in the interactive database (link above).

Largest ARCTURUS THERAPEUTICS HOLDINGS INC. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 26,917,000 shares outstanding at the time of that meeting.

Fund voting reports: top ARCTURUS THERAPEUTICS HOLDINGS INC. shareholders by shares voted on “Approval, by non-binding advisory vote, of the resolution approving the Company's Named…”, 2023-2024
#Asset manager % of shares outstanding
1Federated Hermes 17.44%
2ARK ETF Trust 6.48%
3Vanguard 4.87%
4Fidelity 3.13%
5Dimensional 1.97%
6BlackRock 1.82%
7State Street 0.89%
8Charles Schwab 0.71%
9Hartford 0.66%
10American Century 0.65%
Institutional-manager reports: top ARCTURUS THERAPEUTICS HOLDINGS INC. shareholders by shares voted on “Approval, by non-binding advisory vote, of the resolution approving the Company's Named…”, 2023-2024
#Asset manager % of shares outstanding
1Federated Hermes 17.44%
2Nikko Asset Management Americas, Inc. 4.15%
3ADAGE CAPITAL PARTNERS GP, L.L.C. 3.46%
4BlackRock 2.47%
5State Street 2.19%
6Putnam 1.94%
7Woodline Partners LP 1.80%
8Wellington 1.66%
9JUPITER ASSET MANAGEMENT LTD 1.56%
10Fidelity 1.37%

Reported ARCTURUS THERAPEUTICS HOLDINGS INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

ARCTURUS THERAPEUTICS HOLDINGS INC. holdings and ownership disclosed for the 2023-2024 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
BlackRock2,564,644 9.53%Form 13F, quarter ended March 31, 2024
State Street1,959,936 7.28%Form 13F, quarter ended March 31, 2024
Vanguard Group1,885,605 7.01%Form 13F, quarter ended March 31, 2024
Dimensional Fund Advisors1,103,820 4.10%Form 13F, quarter ended March 31, 2024
Morgan Stanley704,878 2.62%Form 13F, quarter ended March 31, 2024
Geode Capital550,263 2.04%Form 13F, quarter ended March 31, 2024
Point72335,378 1.25%Form 13F, quarter ended March 31, 2024
Wellington Management285,115 1.06%Form 13F, quarter ended March 31, 2024
Northern Trust236,942 0.88%Form 13F, quarter ended March 31, 2024
JPMorgan Chase203,607 0.76%Form 13F, quarter ended March 31, 2024

Percentages above are of 26,917,000 shares outstanding, as reported by ARCTURUS THERAPEUTICS HOLDINGS INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At ARCTURUS THERAPEUTICS HOLDINGS INC.'s shareholder meeting held June 14, 2024, in the 2023-2024 proxy season, 209 asset managers reported votes on at least one of its 11 ballot items in their SEC Form N-PX filings, covering 2,733 separate fund positions. On the most widely held item on that ballot — Approval, by non-binding advisory vote, of the resolution approving the Company's Named… — ARCTURUS THERAPEUTICS HOLDINGS INC.'s filing reports the proposal as approved, with 95% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: ARCTURUS THERAPEUTICS HOLDINGS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 14, 2024.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ARCTURUS THERAPEUTICS HOLDINGS INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

ARCTURUS THERAPEUTICS HOLDINGS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.

Cite this page

Proxy Votes Now, “ARCTURUS THERAPEUTICS HOLDINGS (ARCT) 2024 Annual Meeting”, https://proxyvotesnow.com/company/arcturus-therapeutics-holdings-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.